Drug Response Profiling Informs Personalized Bridging to Cell Therapy for Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaFabio D. Steffen, Jean‐Pierre Bourquin, Sarah Elitzur et al.|Blood|2023Cited by 1
ADVANCED DRUG RESPONSE PROFILING AND IMMUNOPHENOTYPING TO PRIORITIZE TREATMENT OPTIONS FOR PEDIATRIC MDS WITH EXCESS BLASTSBen Haladik, Kaan Boztuǧ, Margarita Maurer‐Granofszky et al.|EJC Paediatric Oncology|2025Cited by 0
INTEGRATED IMMUNOPHENOTYPING AND DRUG RESPONSE PROFILING REVEALS SUBTYPE-SPECIFIC SUSCEPTIBILITIES IN PEDIATRIC MDS WITH EXCESS BLASTSNastassja Scheidegger-Egloff, Beat Bornhäuser, Silvia Gutnik et al.|EJC Paediatric Oncology|2025Cited by 0
Drug response profiling guides precision therapy in relapsed and refractory childhood acute lymphoblastic leukemiaFabio D. Steffen, Jean‐Pierre Bourquin, Andrej Lissat et al.|medRxiv|2026Cited by 0